Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB) (click to learn more) AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Nanobiotix SA NBTX

Healthcare Biotechnology
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:NBTX)

Voting Rights and Shares Capital of the Company

GlobeNewswire 21 hours ago

Voting Rights and Shares Capital of the Company

GlobeNewswire January 13, 2026

Voting Rights and Shares Capital of the Company

GlobeNewswire December 17, 2025

NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris

GlobeNewswire December 15, 2025

Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook

GlobeNewswire November 24, 2025

Voting Rights and Shares Capital of the Company

GlobeNewswire November 14, 2025

NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations

GlobeNewswire November 13, 2025

NANOBIOTIX to Participate in Jefferies London Healthcare Conference

GlobeNewswire November 11, 2025

NANOBIOTIX to Participate in Investor Conferences the Week of November 10th

GlobeNewswire November 3, 2025
View More News ››

Opinion & Analysis (NDAQ:NBTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NBTX)

NBTX....on watch up in PM open

Trading at $12.65 on low vol
Iseneschal - September 18, 2025
View more Bullboard ››

Coelacanth Energy Inc.

Coelacanth Energy Inc.

Coelacanth Energy Inc., an oil and natural gas company, engages in the acquisition, development, exploration, and production ...
View More »

Podcasts